SGLT-2 inhibitors as promising therapeutics for non-alcoholic fatty liver disease: pathophysiology, clinical outcomes, and future directions

QR Code

SGLT-2 inhibitors as promising therapeutics for non-alcoholic fatty liver disease: pathophysiology, clinical outcomes, and future directions

Naser Eddin Gharaibeh, Marie-Noel Rahhal, Leili Rahimi, Faramarz Ismail-BeigiDepartment of Medicine, Case Western Reserve University, University Hospitals Cleveland Medical Center, Cleveland, OH, 44106, USAAbstract: Nonalcoholic fatty liver disease (NAFLD) is increasingly recognized as a major expan...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Gharaibeh NE, Rahhal MN, Rahimi L, Ismail-Beigi F
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2019
Sujets:	Fatty liver insulin resistance beta-oxidation liver biopsy de novo lipid synthesis Specialties of internal medicine RC581-951
Accès en ligne:	https://doaj.org/article/22d788df11744ba6b7f59009abbb9ec9
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Diagnostic significance of clinical and laboratory indices in predicting non-alcoholic fatty liver disease during screening studies
par: Aleksandr E. Nosov, et autres
Publié: (2021)

Liver biopsy in the quantitative assessment of liver fibrosis in nonalcoholic fatty liver disease
par: Gwyneth Shook Ting Soon, et autres
Publié: (2021)

The Contribution of Dietary Fructose to Non-alcoholic Fatty Liver Disease
par: Siyu Yu, et autres
Publié: (2021)

The Role of Notch Signaling Pathway in Non-Alcoholic Fatty Liver Disease
par: Hao Xu, et autres
Publié: (2021)

Body Mass Index and Indicators of Lipid Exchange in Liver Steatosis of Alcoholic and Nonalcoholic Genesis in Residents of Rural Area: Similarities and Differences
par: N. V. Mikhaylova, et autres
Publié: (2019)

Current concepts of the pathogenesis of non-alcoholic fatty liver disease
par: Evgenia Pavlovna Kosobyan, et autres
Publié: (2010)

Liver X Receptors Suppress Activity of Cholesterol and Fatty Acid Synthesis Pathways To Oppose Gammaherpesvirus Replication
par: P. T. Lange, et autres
Publié: (2018)

Integrative lipidomic and transcriptomic study unravels the therapeutic effects of saikosaponins A and D on non-alcoholic fatty liver disease
par: Xiaojiaoyang Li, et autres
Publié: (2021)

Glucocorticoid-Induced Fatty Liver Disease
par: Rahimi L, et autres
Publié: (2020)

Non-invasive Diagnostics of Liver Fibrosis
par: Mihaylov R., et autres
Publié: (2017)

Association of insulin resistance and non-alcoholic fatty liver disease
par: Ekaterina E. Mishina, et autres
Publié: (2021)

Identification of key genes and pathways in mild and severe nonalcoholic fatty liver disease by integrative analysis
par: Jin Feng, et autres
Publié: (2021)

MAFLD Criteria May Overlook a Subtype of Patient with Steatohepatitis and Significant Fibrosis
par: Huang J, et autres
Publié: (2021)

Blancos terapéuticos potenciales para revertir la cirrosis hepática
par: García B,Leonel, et autres
Publié: (2007)

Cytoprotective and suicidal signaling in oxidative stress
par: Videla,Luis A
Publié: (2010)

Non-Alcoholic Fatty Liver Disease (NAFLD) and Potential Links to Depression, Anxiety, and Chronic Stress
par: Sue Shea, et autres
Publié: (2021)

Effect of Saxagliptin, a Dipeptidyl Peptidase 4 Inhibitor, on Non-Alcoholic Fatty Liver Disease
par: Chen L, et autres
Publié: (2020)

Varied Relationship of Lipid and Lipoprotein Profiles to Liver Fat Content in Phenotypes of Metabolic Associated Fatty Liver Disease
par: Tingfeng Wu, et autres
Publié: (2021)

Ochratoxin A Induces Steatosis via PPARγ-CD36 Axis
par: Qian-Wen Zheng, et autres
Publié: (2021)

Non-Alcoholic Fatty Liver Disease and Hypothyroidism: Review of Clinical and Experimental Studies
par: Tetiana Ranhulova
Publié: (2021)

Immunohistochemical Identification of AQP1 in Livers of the High-fat Diet Rats
par: Wang,Jinbao, et autres
Publié: (2019)

Accumulation of Genetic and Epigenetic Alterations in the Background Liver and Emergence of Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease
par: Satoru Hagiwara, et autres
Publié: (2021)

Testosterone deficiency and non-alcoholic fatty liver disease in men with type 2 diabetes mellitus
par: Irina A. Khripun, et autres
Publié: (2019)

Astragaloside IV Alleviates Liver Inflammation, Oxidative Stress and Apoptosis to Protect Against Experimental Non-Alcoholic Fatty Liver Disease
par: Liang XY, et autres
Publié: (2021)

Causes of death in patients with Non-alcoholic Fatty Liver Disease (NAFLD), alcoholic liver disease and chronic viral Hepatitis B and C
par: Pegah Golabi, et autres
Publié: (2022)

Non-Alcoholic Fatty Liver Disease as a Risk for Colorectal Cancer Development and the Role of Screening Colonoscopy in Clinical Practice
par: Cosmas Rinaldi Adithya Lesmana, et autres
Publié: (2019)

The Ameliorative Effects of Saikosaponin in Thioacetamide-Induced Liver Injury and Non-Alcoholic Fatty Liver Disease in Mice
par: Geng-Ruei Chang, et autres
Publié: (2021)

Hepatitis sifilítica en paciente infectado con el virus de inmunodeficiencia humana
par: PIZARRO P.,ROLANDO, et autres
Publié: (2001)

Alteraciones de la tolerancia a la glucosa y frecuencia de síndrome metabólico en pacientes con enfermedad por hígado graso no alcohólico
par: Araya Q,A. Verónica, et autres
Publié: (2006)

Liraglutide ameliorates nonalcoholic fatty liver disease in diabetic mice via the IRS2/PI3K/Akt signaling pathway
par: Yang P, et autres
Publié: (2019)

Metformin treatment reverses high fat diet- induced non-alcoholic fatty liver diseases and dyslipidemia by stimulating multiple antioxidant and anti-inflammatory pathways
par: Tahmina Yasmin, et autres
Publié: (2021)

Effects of DHA dietary intervention on hepatic lipid metabolism in apolipoprotein E-deficient and C57BL/6J wild-type mice
par: Jingjing Xu, et autres
Publié: (2021)

Clinical and Metabolic Characteristics of Non-Alcoholic Fatty Liver Disease Patients in Saudi Arabia: Data from the Systematic Observatory Liver Disease (SOLID) Registry
par: Alswat K, et autres
Publié: (2021)

Risk of Non-Alcoholic Fatty Liver Disease in Xanthelasma Palpebrarum
par: Chen HW, et autres
Publié: (2021)

Nonalcoholic fatty liver disease: cause or consequence of insulin resistance?
par: Ekaterina E. Mishina, et autres
Publié: (2017)

Actualización en el diagnóstico y manejo del daño hepático agudo grave en el embarazo
par: Sepulveda-Martinez,Alvaro, et autres
Publié: (2015)

The Impact of Vitamin D in Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study in Patients with Morbid Obesity
par: Borges-Canha M, et autres
Publié: (2021)

Adiponutrin and Adiponectin Gene Variants in Indonesian Patients with Non-Alcoholic Fatty Liver Disease: a Preliminary Study
par: Rayvita AN Meagratia, et autres
Publié: (2021)

Verapamil induces autophagy to improve liver regeneration in non-alcoholic fatty liver mice
par: Jian-Lin Lai, et autres
Publié: (2021)

Potential relation between non-alcoholic fatty liver disease and glycemic and metabolic parameters in subjects without diabetes
par: H. Naguib, et autres
Publié: (2021)